Publicacións nas que colabora con Ciro Casanova Macario (82)

2024

  1. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  2. Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers

    Antioxidants, Vol. 13, Núm. 2, pp. 156

  3. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort

    Respirology, Vol. 27, Núm. 4, pp. 286-293

  2. Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease

    Respiratory Research, Vol. 23, Núm. 1

2021

  1. COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort

    Respiratory research, Vol. 22, Núm. 1, pp. 36

  2. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD

    Chest, Vol. 160, Núm. 3, pp. 872-878

  3. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

  4. Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12

  5. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients

    Archivos de Bronconeumologia, Vol. 57, Núm. 8, pp. 533-539

2020

  1. A delphi consensus document on the use of single-inhaler fixed-dose triple therapies in copd patients

    International Journal of COPD, Vol. 15, pp. 1801-1811

  2. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

  3. Somatotypes trajectories during adulthood and their association with copd phenotypes

    ERJ Open Research, Vol. 6, Núm. 3, pp. 1-9

2019

  1. External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study

    COPD: Journal of Chronic Obstructive Pulmonary Disease

  2. Plasma metabolomics and clinical predictors of survival differences in COPD patients

    Respiratory Research, Vol. 20, Núm. 1

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

  2. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort

    PLoS ONE, Vol. 13, Núm. 2

  3. Comparison of the 2017 and 2015 global initiative for chronic obstructive lung disease reports impact on grouping and outcomes

    American Journal of Respiratory and Critical Care Medicine, Vol. 197, Núm. 4, pp. 463-469

  4. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

    Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483